JFG
XFOR icon

Jefferies Financial Group’s X4 Pharmaceuticals XFOR Stock Holding History

Jefferies Financial Group’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.4K Sell
19,474
-6,644
-25% -$24.9K ﹤0.01% 1620
2025
Q4 		$104K Buy
+26,118
New +$94.9K ﹤0.01% 1698

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Jefferies Financial Group's XFOR Position: Q1 2026 in Review

Jefferies Financial Group reduced its X4 Pharmaceuticals (XFOR) stake by 25% in Q1 2026, selling an estimated $24.9K and leaving 19,474 shares worth $80.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Jefferies Financial Group first reported a position in XFOR in Q4 2025 and has held it in 2 quarters since. The position peaked at $104K in Q4 2025. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • Jefferies Financial Group held 19,474 shares of X4 Pharmaceuticals worth $80.4K as of Q1 2026.
  • Jefferies Financial Group sold 6,644 X4 Pharmaceuticals shares in Q1 2026, an estimated $24.9K.
  • X4 Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1620 holding.
  • Jefferies Financial Group first reported a position in X4 Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Jefferies Financial Group's X4 Pharmaceuticals position peaked at $104K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.